Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Anti-Cancer Drugs
|
November 12, 2015
Peptidomimetic suppresses proliferation and invasion of gastric cancer cells by fibroblast growth factor 2 signaling cascade blockage
Wulan Li, Xiaojing Du, Qiuxiang Chen, et al.
Frontiers in Pharmacology
|
October 12, 2020
Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect
Qian Chen, Min Zhu, Jingwen Xie, et al.
Bioorganic Chemistry
|
October 27, 2023
Green synthesis and anti-tumor efficacy via inducing pyroptosis of novel 1H-benzo[e]indole-2(3H)-one spirocyclic derivatives
Jianzhang Wu, Xin Liu, Jie Zhang, et al.
European Journal of Medicinal Chemistry
|
November 26, 2016
Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
Jianzhang Wu, Shoubiao Wu, Lingyi Shi, et al.
Current Medicinal Chemistry
|
June 7, 2024
Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds
Chunhui Nian, Xin Gan, Qunpeng Liu, et al.
Anti-Cancer Drugs
|
December 19, 2014
The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer
Chaochao Xu, Wulan Li, Peihong Qiu, et al.
European Journal of Medicinal Chemistry
|
December 31, 2017
Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds
Jiabing Wang, Di Yun, Jiali Yao, et al.
Current Medicinal Chemistry
|
February 15, 2024
Discovery of Pyroptosis-inducing Drugs and Antineoplastic Activity based on the ROS/ER Stress/Pyroptosis Axis
Xin Gan, Jingwen Xie, Zhaojun Dong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 30, 2022
Rational design, synthesis, and pharmacological characterisation of dicarbonyl curcuminoid analogues with improved stability against lung cancer via ROS and ER stress mediated cell apoptosis and pyroptosis
Tao Wei, Zhiwei Zheng, Xiaoyan Wei, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 19, 2017
A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration
Jianzhang Wu, Xiaojing Du, Wulan Li, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Anti-Cancer Drugs
|
November 12, 2015
Peptidomimetic suppresses proliferation and invasion of gastric cancer cells by fibroblast growth factor 2 signaling cascade blockage
Wulan Li, Xiaojing Du, Qiuxiang Chen, et al.
Frontiers in Pharmacology
|
October 12, 2020
Design and Synthesis of Novel Nordihydroguaiaretic Acid (NDGA) Analogues as Potential FGFR1 Kinase Inhibitors With Anti-Gastric Activity and Chemosensitizing Effect
Qian Chen, Min Zhu, Jingwen Xie, et al.
Bioorganic Chemistry
|
October 27, 2023
Green synthesis and anti-tumor efficacy via inducing pyroptosis of novel 1H-benzo[e]indole-2(3H)-one spirocyclic derivatives
Jianzhang Wu, Xin Liu, Jie Zhang, et al.
European Journal of Medicinal Chemistry
|
November 26, 2016
Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
Jianzhang Wu, Shoubiao Wu, Lingyi Shi, et al.
Current Medicinal Chemistry
|
June 7, 2024
Synthesis and Anti-gastric Cancer Activity by Targeting FGFR1 Pathway of Novel Asymmetric Bis-chalcone Compounds
Chunhui Nian, Xin Gan, Qunpeng Liu, et al.
Anti-Cancer Drugs
|
December 19, 2014
The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer
Chaochao Xu, Wulan Li, Peihong Qiu, et al.
European Journal of Medicinal Chemistry
|
December 31, 2017
Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds
Jiabing Wang, Di Yun, Jiali Yao, et al.
Current Medicinal Chemistry
|
February 15, 2024
Discovery of Pyroptosis-inducing Drugs and Antineoplastic Activity based on the ROS/ER Stress/Pyroptosis Axis
Xin Gan, Jingwen Xie, Zhaojun Dong, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
August 30, 2022
Rational design, synthesis, and pharmacological characterisation of dicarbonyl curcuminoid analogues with improved stability against lung cancer via ROS and ER stress mediated cell apoptosis and pyroptosis
Tao Wei, Zhiwei Zheng, Xiaoyan Wei, et al.
Apoptosis : an International Journal on Programmed Cell Death
|
March 19, 2017
A novel non-ATP competitive FGFR1 inhibitor with therapeutic potential on gastric cancer through inhibition of cell proliferation, survival and migration
Jianzhang Wu, Xiaojing Du, Wulan Li, et al.
Page
of 4